AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

INDIA'S RANBAXY TO FILE ANTI RETRO VIRAL PRODUCTS WITH USFDA.

AsiaPulse News

| August 02, 2004 | COPYRIGHT 2004 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

NEW DELHI, Aug 2 Asia Pulse - Ranbaxy Laboratories (BSE:RANB) has initiated the process to file its Anti Retro Viral (ARV) products with the US Food and Drug Administration (USFDA) with first filing likely before this year end.

The filing would take place under the expedited review process of the USFDA for the US ...

Related articles from newspapers, magazines, journals, and more
RANBAXY LAUNCHES NEXT GENERATION ANTI-RETRO VIRAL PRODUCT.
News wire article from: AsiaPulse News February 5, 2003 700+ words
NEW DELHI, Feb 5 Asia Pulse - Ranbaxy (BSE:RANB) has announced the launch of the next generation anti-retroviral (ARV) product ABACAVIR for the first time in India. The product would be marketed under the brand name VIROL as 30 mg formulation in India. Abacavir belongs to the class of ARVs called
WHO APPROVES RANBAXY'S DRUG ABACAVIR.
News wire article from: AsiaPulse News August 4, 2008 700+ words
...Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list. Anti-retro viral drugs are used for the treatment...the pharma company has 18 anti-retro viral drugs in the WHO pre-qualification...
WHO approves Ranbaxy's drug Abacavir.
News wire article from: PTI - The Press Trust of India Ltd. August 1, 2008 700+ words
...Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list. Anti-retro viral drugs are used for the treatment...the pharma company has 18 anti-retro viral drugs in the WHO pre-qualification...
BRIEFING - ASIA HEALTH - AUG 4, 2008.
News wire article from: AsiaPulse News August 4, 2008 700+ words
...said the World Health Organisation has approved its anti-retro viral drug Abacavir 300 mg tablets in pre-qualification list. Anti-retro viral drugs are used for the treatment of infections by...
GlaxoSmithKline Announces Agreement With the Government of Burundi to Increase...
Press release article from: PR Newswire April 29, 2001 700+ words
...agreement, Burundi will receive anti-retro viral medicines at heavily discounted...taxes on all drugs including anti-retro virals. "We hope that other...offers preferential prices on anti-retro viral medicines to UN-supported and...
STRIDES GETS USFDA'S TENTATIVE NOD FOR STAVUDINE CAPSULES.
News wire article from: AsiaPulse News August 29, 2006 700+ words
...has received tentative approval from USFDA for the anti-retro viral (ARV) drug, Stavudine. The company informed the...opportunity for Strides to commercialise Stavudine a key anti-retro viral in the treatment of AIDS," company Vice Chairman...
BRIEFING - ASIA HEALTH - JUNE 22, 2005.
News wire article from: AsiaPulse News June 22, 2005 700+ words
...has received tentative approval from USFDA for its Anti-Retro Viral (ARV) drug Nevirapine. Nevirapine is in the class...Food & Drug Administration (USFDA) for the Anti-Retro Viral (ARV) drug Nevirapine. Nevirapine is in the class...
Experts tell government to address AIDS.
News wire article from: PAC - Pacific Islands Broadcasting Association April 25, 2006 700+ words
...a lot of money from having to buy the very costly anti-retro viral treatment for HIV/AIDS patients and on hiring foreign...there were currently 360 HIV/AIDS patients on the anti-retro viral treatment and the Foundation's assistance would...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA